0001209191-22-014336.txt : 20220301
0001209191-22-014336.hdr.sgml : 20220301
20220301183112
ACCESSION NUMBER: 0001209191-22-014336
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220225
FILED AS OF DATE: 20220301
DATE AS OF CHANGE: 20220301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Condella Sarah
CENTRAL INDEX KEY: 0001839989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35092
FILM NUMBER: 22700391
MAIL ADDRESS:
STREET 1: 441 CHARMANY DRIVE
CITY: MADISON
STATE: WI
ZIP: 53719
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXACT SCIENCES CORP
CENTRAL INDEX KEY: 0001124140
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 204782291
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5505 ENDEAVOR LANE
CITY: MADISON
STATE: WI
ZIP: 53719
BUSINESS PHONE: 608-284-5700
MAIL ADDRESS:
STREET 1: 5505 ENDEAVOR LANE
CITY: MADISON
STATE: WI
ZIP: 53719
FORMER COMPANY:
FORMER CONFORMED NAME: EXACT CORP
DATE OF NAME CHANGE: 20000919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-25
0
0001124140
EXACT SCIENCES CORP
EXAS
0001839989
Condella Sarah
C/O EXACT SCIENCES CORP.
5505 ENDEAVOR LANE
MADISON
WI
53719
0
1
0
0
SVP, Human Resources
Common Stock
2022-02-25
4
S
0
4800
74.05
D
83377
D
Common Stock
2022-02-25
4
S
0
680
75.15
D
82697
D
Common Stock
4922
I
Held in 401(k) Plan
Restricted Stock Units
2022-02-25
4
A
0
15817
0.00
A
Common Stock
15817
15817
D
The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in February 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.52 to $74.46, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.55 to $75.28, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
In addition to the shares of Common Stock reported on this Form 4, which total 87,619 shares, Ms. Condella also holds, in the aggregate, an additional 86,779 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
Each restricted stock unit represents a contingent right to receive one share of common stock.
These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.
/s/ Sarah Condella by Mark R. Busch, attorney-in-fact
2022-03-01